Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Alx Oncology Holdings (ALXO) Shares Outstanding (2019 - 2026)

Alx Oncology Holdings' Shares Outstanding history spans 5 years, with the latest figure at $50.0 million for Q4 2023.

  • On a quarterly basis, Shares Outstanding rose 22.25% to $50.0 million in Q4 2023 year-over-year; TTM through Dec 2023 was $50.0 million, a 22.25% increase, with the full-year FY2023 number at $50.0 million, up 22.25% from a year prior.
  • Shares Outstanding hit $50.0 million in Q4 2023 for Alx Oncology Holdings, up from $41.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding for ALXO hit a ceiling of $50.0 million in Q4 2023 and a floor of $3.2 million in Q2 2019.
  • Historically, Shares Outstanding has averaged $31.1 million across 5 years, with a median of $40.5 million in 2021.
  • Biggest five-year swings in Shares Outstanding: grew 0.16% in 2020 and later soared 1173.32% in 2021.
  • Tracing ALXO's Shares Outstanding over 5 years: stood at $3.2 million in 2019, then skyrocketed by 1158.14% to $39.8 million in 2020, then rose by 1.86% to $40.6 million in 2021, then rose by 0.68% to $40.9 million in 2022, then rose by 22.25% to $50.0 million in 2023.
  • Business Quant data shows Shares Outstanding for ALXO at $50.0 million in Q4 2023, $41.2 million in Q3 2023, and $41.0 million in Q2 2023.